Poor performance status, urban residence and female sex predict inferior survival in pediatric advanced stage mature B-NHL in an Indian tertiary care center

References

• Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008.
   Google Scholar
• Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390.
   PubMed Web of Science ®Google Scholar
• Woessmann W, Seidemann K, Mann G, Zimmermann M, Burkhardt B, Oschlies I, et al. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: A report of the BFM Group Study NHL-BFM95. Blood. 2005;105(3):948–958.
   PubMed Web of Science ®Google Scholar
• Patte C, Auperin A, Gerrard M, Michon J, Pinkerton R, Sposto R, et al. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: It is possible to reduce treatment for the early responding patients. Blood. 2007;109(7):2773–2780.
   PubMed Web of Science ®Google Scholar
• Cairo MS, Gerrard M, Sposto R, Auperin A, Pinkerton CR, Michon J, et al. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood. 2007;109(7):2736–2743.
   PubMed Web of Science ®Google Scholar
• Baez F, Pillon M, Manfredini L, Ocampo E, Mendez G, Ortiz R, et al. Treatment of pediatric non-Hodgkin lymphomas in a country with limited resources: Results of the first national protocol in Nicaragua. Pediatr Blood Cancer. 2008;50(1):148–152.
   PubMed Web of Science ®Google Scholar
• Klumb CE, Schramm MT, De Resende LMM, Carriço MK, Coelho AM, de Meis E, et al. Treatment of children with B-cell non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil. J Pediatr Hematol Oncol. 2004;26(7):462–468.
   PubMed Web of Science ®Google Scholar
• Acquatella G, Insausti CL, García R, Gómez R, Hernández M, Carneiro M, et al. Outcome of children with B cell lymphoma in Venezuela with the LMB-89 protocol. Pediatr Blood Cancer. 2004;43(5):580–586.
   PubMed Web of Science ®Google Scholar
• Moleti ML, Al-Hadad SA, Al-Jadiry MF, Al-Darraji AF, Al-Saeed RM, De Vellis A, et al. Treatment of children with B-cell non-Hodgkin lymphoma in a low-income country. Pediatr Blood Cancer. 2011;56(4):560–567.
   PubMed Web of Science ®Google Scholar
• Sengar Manju, Akhade A., Nair R., Menon H., Shet T., Gujral S. E. Sridhar. A retrospective audit of clinicopathological attributes and treatment outcomes of adolescent and young adult non-Hodgkin lymphomas from a tertiary care center. Indian J Med Paediatr Oncol 2011;32(4):197–203.
   PubMedGoogle Scholar
• Cairo MS, Sposto R, Gerrard M, Auperin A, Goldman SC, Harrison L, et al. Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (> = 15 Sources), are associated with an increased risk of treatment failure in children and adolescents with mature B-Cell Non-Hodgkin's Lymphoma: Results of the FAB LMB 96 study. J Clin Oncol. 2012;30(4):387–393.
   PubMed Web of Science ®Google Scholar
• Onciu M, Schlette E, Zhou Y, Raimondi SC, Giles FJ, Kantarjian HM, et al. Secondary chromosomal abnormalities predict outcome in pediatric and adult high-stage Burkitt lymphoma. Cancer. 2006;107(5):1084–1092.
   PubMed Web of Science ®Google Scholar
• Poirel HA, Cairo MS, Heerema NA, Swansbury J, Aupérin A, Launay E, et al. Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study. Leukemia. 2009;23(2):323–331.
   PubMed Web of Science ®Google Scholar
• Nelson M, Perkins SL, Dave BJ, Coccia PF, Bridge JA, Lyden ER, et al. An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961. Br J Haematol. 2010;148(4):600–610.
   PubMed Web of Science ®Google Scholar
• Murphy SB, Fairclough DL, Hutchison RE, Berard CW. Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution. J Clin Oncol Off J Am Soc Clin Oncol. 1989;7(2):186–193.
   Google Scholar
• Khadilkar VV, Khadilkar AV. Revised Indian Academy of Pediatrics 2015 growth charts for height, weight and body mass index for 5–18-source-old Indian children. Indian J Endocrinol Metab. 2015;19(4):470–476.
   PubMedGoogle Scholar
• Lansky SB, List MA, Lansky LL, Ritter-Sterr C, Miller DR. The measurement of performance in childhood cancer patients. Cancer. 1987;60(7):1651–1656.
   PubMed Web of Science ®Google Scholar
• ECOG Performance Status [Internet]. ECOG-ACRIN. [cited 2016 Dec 28]. Available from: http://ecog-acrin.org/resources/ecog-performance-status
   Google Scholar
• Reiter A, Schrappe M, Tiemann M, Ludwig WD, Yakisan E, Zimmermann M, et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood. 1999;94(10):3294–3306.
   PubMed Web of Science ®Google Scholar
• Fujita N, Kobayashi R, Takimoto T, Nakagawa A, Ueda K, Horibe K. Results of the Japan Association of Childhood Leukemia Study (JACLS) NHL-98 protocol for the treatment of B-cell non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia in childhood. Leuk Lymphoma. 2011;52(2):223–229.
   PubMed Web of Science ®Google Scholar
• Müller J, Csóka M, Jakab Z, Ponyi A, Erlaky H, Kovács G. Treatment of pediatric non-Hodgkin lymphoma in Hungary: 15 sources experience with NHL-BFM 90 and 95 protocols. Pediatr Blood Cancer. 2008;50(3):633–635.
   PubMed Web of Science ®Google Scholar
• Kavan P, Kabickova E, Gajdos P, Koutecky J, Kodet R, McClain KL. Treatment of pediatric B-cell non-Hodgkin's lymphomas at the Motol Hospital in Prague, Czech Republic: Results based on the NHL BFM 90 protocols. Pediatr Hematol Oncol. 1999;16(3):201–212.
   PubMed Web of Science ®Google Scholar
• Ziegler JL. Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience. N Engl J Med. 1977;297(2):75–80.
   PubMed Web of Science ®Google Scholar
• Arora RS, Eden TOB, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer. 2009;46(4):264–273.
   PubMedGoogle Scholar
• Goldman S, Smith L, Anderson JR, Perkins S, Harrison L, Geyer MB, et al. Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: A Children's Oncology Group report. Leukemia. 2013;27(5):1174–1177.
   PubMed Web of Science ®Google Scholar